newsfilter
← Latest News
PR Newswire·

Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets

Patented Tech Easily Transforms Distillate into "Free flow" Powder Matrix PHILADELPHIA, Sept. 20, 2022 /PRNewswire/ -- Zelira Therapeutics Ltd ((ASX:ZLD, OTCQB:ZLDAF), a global leader in the research, development and commercialization of clinically v